Stockscreener 앱 받기
37.70
0.66%
-0.25
시간 외 거래:
37.70
전일 마감가:
$37.95
열려 있는:
$37.95
하루 거래량:
1.36M
Relative Volume:
1.70
시가총액:
$2.19B
수익:
$32.87M
순이익/손실:
$674.31M
주가수익비율:
3.3187
EPS:
11.36
순현금흐름:
$-330.11M
1주 성능:
+2.50%
1개월 성능:
+4.09%
6개월 성능:
+19.00%
1년 성능:
-20.43%
1일 변동 폭
$36.94
$37.95
1주일 범위
$35.72
$38.45
52주 변동 폭
$23.41
$62.58
Agios Pharmaceuticals Inc Stock (AGIO) Company Profile
명칭
Agios Pharmaceuticals Inc
전화
617-649-8600
주소
88 SIDNEY STREET, CAMBRIDGE, MA
AGIO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AGIO
Agios Pharmaceuticals Inc
|
37.70 | 2.20B | 32.87M | 674.31M | -330.11M | 11.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-24 | 개시 | H.C. Wainwright | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-10-10 | 재개 | Raymond James | Outperform |
| 2024-09-27 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-02-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-02-03 | 개시 | Piper Sandler | Overweight |
| 2022-11-17 | 업그레이드 | Goldman | Sell → Neutral |
| 2022-07-27 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-12-03 | 개시 | BofA Securities | Buy |
| 2021-07-30 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-07-01 | 개시 | Raymond James | Mkt Perform |
| 2021-06-10 | 개시 | H.C. Wainwright | Buy |
| 2021-03-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-03-01 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-02-26 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-10-22 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-03-04 | 개시 | Barclays | Equal Weight |
| 2019-11-26 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2019-05-23 | 재개 | Goldman | Neutral |
| 2019-02-15 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2018-09-25 | 개시 | Leerink Partners | Mkt Perform |
| 2018-05-23 | 개시 | Citigroup | Buy |
| 2018-04-11 | 재확인 | Credit Suisse | Outperform |
| 2018-02-15 | 재확인 | Needham | Buy |
| 2018-02-15 | 재확인 | SunTrust | Buy |
| 2017-09-15 | 개시 | RBC Capital Mkts | Outperform |
| 2017-08-10 | 재확인 | Needham | Buy |
| 2017-08-08 | 재확인 | SunTrust | Buy |
| 2017-08-02 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2017-06-26 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-01-17 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2016-10-24 | 개시 | Needham | Buy |
| 2016-06-13 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2016-05-18 | 재확인 | SunTrust | Buy |
모두보기
Agios Pharmaceuticals Inc 주식(AGIO)의 최신 뉴스
Aug Ideas: Is Agios Pharmaceuticals Inc. stock a top performer YTDTrade Exit Report & Accurate Technical Buy Alerts - khodrobank.com
Is it too late to sell Agios Pharmaceuticals Inc.Share Buyback & Consistent Income Trade Recommendations - newser.com
Pattern recognition hints at Agios Pharmaceuticals Inc. upsideJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - newser.com
Trading Action: Is Agios Pharmaceuticals Inc a defensive stockMarket Trend Review & Verified Stock Trade Ideas - khodrobank.com
Rhumbline Advisers Reduces Stock Holdings in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Agios drops as FDA delays review of thalassemia drug - MSN
Support Test: Is Agios Pharmaceuticals Inc a defensive stockJuly 2025 Earnings & Accurate Buy Signal Alerts - خودرو بانک
What is the long term forecast for Apellis Pharmaceuticals Inc stock2025 Trading Recap & Fast Entry High Yield Tips - khodrobank.com
How to escape a deep drawdown in Agios Pharmaceuticals Inc.Risk Management & Long Hold Capital Preservation Tips - newser.com
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
Using Ichimoku Cloud for Agios Pharmaceuticals Inc. technicalsEarnings Risk Summary & Technical Buy Zone Confirmation - newser.com
Quarterly Risk: Is COOTW stock heavily shortedMarket Risk Summary & Technical Buy Zone Confirmation - خودرو بانک
Tools to assess Agios Pharmaceuticals Inc.’s risk profileWeekly Profit Report & Expert Curated Trade Setup Alerts - newser.com
Agios Pharmaceuticals’ SWOT analysis: FDA delay impacts stock outlook By Investing.com - Investing.com Canada
Agios Pharmaceuticals’ SWOT analysis: FDA delay impacts stock outlook - Investing.com
Rhumbline Advisers Sells 7,666 Shares of Agios Pharmaceuticals, Inc. $AGIO - Defense World
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives $56.00 Average PT from Analysts - MarketBeat
Tools to monitor Agios Pharmaceuticals Inc. recovery probabilityJuly 2025 Short Interest & Stepwise Entry/Exit Trade Alerts - newser.com
Forecast Cut: What is Agios Pharmaceuticals Incs market position2025 Trading Volume Trends & Low Volatility Stock Recommendations - khodrobank.com
What momentum shifts mean for Agios Pharmaceuticals Inc.July 2025 Opening Moves & Community Verified Watchlist Alerts - newser.com
Rate Hike: What are LSAKs recent SEC filings showingPortfolio Update Report & Community Driven Trade Alerts - خودرو بانک
Risk Analysis: Is Agios Pharmaceuticals Inc stock good for income investorsPortfolio Profit Report & AI Driven Stock Movement Reports - khodrobank.com
Day Trade: Will Agios Pharmaceuticals Inc outperform tech stocksDividend Hike & Community Verified Trade Signals - خودرو بانک
Aug Macro: Can IBIO stock double in the next yearJuly 2025 Levels & Reliable Intraday Trade Plans - خودرو بانک
Real time alert setup for Agios Pharmaceuticals Inc. performance2025 Price Momentum & Consistent Income Trade Ideas - newser.com
Forecasting Agios Pharmaceuticals Inc. price range with options dataWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
What does recent volatility data suggest for Agios Pharmaceuticals Inc.July 2025 Opening Moves & Detailed Earnings Play Strategies - newser.com
AGIO Investors Have Opportunity to Join Agios Pharmaceuticals, Inc. Fraud Investigation With the Schall Law Firm - Business Wire
Atavistik Bio Expands Leadership Team with Appointment of Susan Pandya, M.D., as Chief Medical Officer - GlobeNewswire Inc.
Surprises Report: Is Agios Pharmaceuticals Inc a good ESG investmentPortfolio Growth Summary & Weekly Market Pulse Updates - خودرو بانک
Insider Selling: Agios Pharmaceuticals (NASDAQ:AGIO) Insider Sells 8,546 Shares of Stock - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc.AGIO - PR Newswire
SCS Capital Management LLC Purchases Shares of 611,098 Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
HC Wainwright Issues Pessimistic Estimate for AGIO Earnings - MarketBeat
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. – AGIO - Louisiana First News
Agios Pharmaceuticals, Inc. $AGIO Shares Purchased by Granahan Investment Management LLC - MarketBeat
Agios Pharmaceuticals, Inc. $AGIO Shares Purchased by Boothbay Fund Management LLC - MarketBeat
Cutter Capital Management LP Trims Holdings in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Adage Capital Partners GP L.L.C. Boosts Stake in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Is Agios Pharmaceuticals Inc. stock technically oversold2025 Bull vs Bear & Real-Time Price Movement Reports - Lancaster City Council
What is the earnings history of Agios Pharmaceuticals Inc.Quarterly Trade Summary & AI Driven Price Predictions - Lancaster City Council
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc.AGIO - MarketScreener
Agios Pharmaceuticals: Why A Delayed FDA Review Could Still Be A Positive (NASDAQ:AGIO) - Seeking Alpha
FDA Review Delay for PYRUKYND Might Change the Case for Investing in Agios Pharmaceuticals (AGIO) - Yahoo Finance
Palo Alto Investors LP Buys Shares of 276,578 Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Northern Trust Corp Has $16.88 Million Position in Agios Pharmaceuticals, Inc. $AGIO - MarketBeat
Agios Pharmaceuticals Inc (AGIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Agios Pharmaceuticals Inc 주식 (AGIO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Scadden David | Director |
Aug 27 '25 |
Option Exercise |
18.09 |
200 |
3,618 |
17,803 |
| Scadden David | Director |
Aug 27 '25 |
Sale |
40.00 |
200 |
8,000 |
17,603 |
1.43%
0.09%
자본화:
|
볼륨(24시간):